We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

There has been recent media coverage concerning a rare atypical femoral fracture that may be a side effect of denosumab (Prolia), an osteoporosis medication manufactured by Amgen. Osteoporosis Canada’s Scientific […]

Get Involved What you can do We were the world’s first-ever osteoporosis-dedicated organization, the first to establish guidelines for long-term treatment and exercise, and the first to introduce fracture risk […]

Standing And Walking Standing and walking puts less strain on the spine than sitting so try to stand and walk as much as possible rather than sitting too much. In the […]

An atypical femoral fracture is an uncommon type of hip fracture which has been associated with long term use of certain osteoporosis medications. This type of hip fracture affects the […]

It is well known that calcium is a necessary nutrient because it plays an essential role in human health, not only for bone development but also for the heart, muscle […]

Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]

After The Fracture Table Of Contents Introduction General Information About Pain After A Fracture Three Stages of Pain from a Fracture Acute Pain – Immediately after a Fracture Sub-acute Pain […]